Neubase Therapeutics (NBSE) Investor Presentation - Slideshow

neubase PRECISE GENOME CONTROL TO ADDRESS CAUSALITY IN DISEASE MARCH 2021 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, expectation ...